Data as of Jul 30
| +0.40 / +0.78%|
The 20 analysts offering 12-month price forecasts for ResMed Inc have a median target of 53.96, with a high estimate of 68.27 and a low estimate of 40.00. The median estimate represents a +4.17% increase from the last price of 51.80.
The current consensus among 22 polled investment analysts is to Buy stock in ResMed Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.